Sector pending / Biological Products, Except Diagnostic SubstancesUpdated 2026-05-10 22:07 UTC

BCBA/VRTX stock hub

BCBA/VRTX has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

BCBA/VRTXis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

151.9T

Buenos Aires Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

BCBA/VRTX

In the news

Latest news · BCBA/VRTX

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E21.5

P25 n/aP50 n/aP75 n/a

Trailing P/E25.3

P25 n/aP50 n/aP75 n/a

ROE24.2

P25 n/aP50 n/aP75 n/a

ROIC28.6

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All BCBA/VRTX market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

197

Groups with data

Currency

USD

Showing 197 of 197 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	AR
Employees	6,400
Employees Change	300%
Employees Change Percent	4.92
Enterprise value	ARS 136.6T
Exchange	Buenos Aires Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Biological Products, Except Diagnostic Substances
Last refreshed	2026-05-10
Market cap	ARS 151.9T
Price	ARS 6,295
Price currency	ARS
Rev Per Employee	2,637,395,997.91x
Sic	2836
Symbol	bcba/VRTX
Website	https://www.vrtx.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	3.94%
EV Earnings	22.79x
EV/EBIT	20.45x
EV/EBITDA	18.68x
EV/FCF	26.65x
EV/Sales	8.03x
FCF yield	3.37%
Forward P/E	21.46x
P/B ratio	5.68x
P/E ratio	25.35x
P/S ratio	9x
PE Ratio10 Y	50.67x
PE Ratio3 Y	27.83x
PE Ratio5 Y	25.86x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	39.25%
EBITDA Margin	40.77%
FCF margin	30.37%
Gross margin	54.39%
Gross Profit	ARS 9.2T
Gross Profit Growth	16.02%
Gross Profit Growth Q	14.36%
Gross Profit Growth3 Y	6.91%
Gross Profit Growth5 Y	11.76%
Net Income	ARS 6T
Net Income Growth Q	59.59%
Net Income Growth3 Y	10%
Net Income Growth5 Y	9.45%
Pretax Margin	42.28%
Profit Margin	35.51%
Profit Per Employee	ARS 936.5M
ROA	12.14
Roa5y	14.82
ROCE	21.21
ROE	24.2
Roe5y	19
ROIC	28.57
Roic5y	37.75

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS Growth Q	61.45
EPS Growth3 Y	10.35
EPS Growth5 Y	9.96
FCF Growth Q	66.37%
FCF Growth3 Y	-1.57%
FCF Growth5 Y	4.01%
OCF Growth Q	74.39%
OCF Growth3 Y	1.35%
OCF Growth5 Y	4.77%
Revenue Growth	10.08x
Revenue Growth Q	7.82x
Revenue Growth3 Y	9.89x
Revenue Growth5 Y	13.75x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	ARS 0.5
Assets	ARS 36.6T
Cash	ARS 10T
Current Assets	ARS 16.4T
Current Liabilities	ARS 5.4T
Debt	ARS 2.7T
Debt EBITDA	ARS 0.38
Debt Equity	ARS 0.1
Debt FCF	ARS 0.54
Equity	ARS 26.7T
Interest Coverage	360.5
Liabilities	ARS 9.8T
Long Term Assets	ARS 20.2T
Long Term Liabilities	ARS 4.4T
Net Cash	ARS 15.2T
Net Cash By Market Cap	ARS 10.01
Net Cash Growth	13.41%
Net Debt EBITDA	ARS -2.21
Net Debt Equity	ARS -0.57
Net Debt FCF	ARS -2.97
Tangible Book Value	ARS 24.7T
Tangible Book Value Per Share	ARS 97,053

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.02
Inventory Turnover	3.56
Net Working Capital	ARS 833.1B
Quick ratio	2.38
Working Capital	ARS 10.8T
Working Capital Turnover	ARS 2,398

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.15%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
200-day SMA	6,321
50-day SMA	6,573.4
50-day SMA vs 200-day SMA	50over200
All Time High	7,380
All Time High Change	-14.7%
All Time High Date	2026-03-10
All Time Low	4,815
All Time Low Change	30.74%
All Time Low Date	2025-08-08
ATR	130.5
Ch YTD	-7.97
High	6,345
High52	7,380
High52 Date	2026-03-10
High52ch	-14.7%
Low	6,240
Low52	4,815
Low52 Date	2025-08-08
Low52ch	30.74%
Ma50ch	-4.24%
Price vs 200-day SMA	-0.41%
RSI	43.68
RSI Monthly	0
RSI Weekly	47.24
Sharpe ratio	0.67x
Sortino ratio	1.01
Total Return	0.15%
Tr YTD	-7.97
Tr1m	-1.02%
Tr1w	-1.25%
Tr3m	-10.2%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	ARS 6.6T
Operating Income Growth	13.9
Operating Income Growth Q	10.45
Operating Income Growth3 Y	2.39
Operating Income Growth5 Y	9.6
Operating margin	39.25

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	253,010,542%
Net Borrowing	-7,552,752,751.8
Shares Insiders	0.21%
Shares Institutions	95.45%
Shares Qo Q	0.08%
Shares Yo Y	-0.15%
Short Ratio	3.22

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	ARS 4.2T
Average Volume	807.5x
Bv Per Share	105,242
CAPEX	ARS -732.6B
Ch1m	-1.02
Ch1w	-1.25
Ch3m	-10.2
Ch6m	5.62
Change	0.32%
Change From Open	0.16
Close	6,275
Days Gap	0.16
Depreciation Amortization	260,290,238,353.7
Dollar Volume	10,575,600
Earnings Date	2026-05-04
EBIT	ARS 6.6T
EBITDA	ARS 6.9T
EPS	ARS 23,294
F Score	6
FCF	ARS 5.1T
FCF EV Yield	3.75x
Financing CF	-2,928,394,589,890
Fiscal Year End	December
Founded	1,989
Goodwill	1,521,739,813,696
Graham Number	2488.46126
Graham Upside	-60.47
Income Tax	ARS 1.1T
Investing CF	-1,825,670,354,550
Is Primary Listing	0
Last Earnings Date	2026-05-04
Last Report Date	2026-03-31
Lynch Fair Value	ARS 2,347
Lynch Upside	-62.72
Ma150	6,585.8
Ma150ch	-4.42%
Ma20	6,346.5
Ma20ch	-0.81%
Net CF	1,132,150,477,150
Open	6,285
P FCF Ratio	29.64
P OCF Ratio	25.93
Position In Range	52.38
Ppne	4,606,479,849,639.5
Price Date	2026-05-08
Price EBITDA	ARS 22.08
Ptbv Ratio	6.16
Relative Volume	2.08x
Revenue	16,879,334,386,600x
SBC By Revenue	5.62x
Share Based Comp	947,994,700,940
Tax By Revenue	6.77x
Tax Rate	16.02%
Tr6m	5.62%
Volume	1,680
Z Score	11.73

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does BCBA/VRTX pay a dividend?

Capital-return profile for this ticker.

Ownership

Who owns BCBA/VRTX?

Insider, institutional, and short-interest positioning.

Institutional ownership

+95.5%

Share of float held by funds and institutions

Insider ownership

+0.2%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

BCBA/VRTX momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

43.7

Neutral momentum band

Price vs 200-day MA

-0.4%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

0.67

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About BCBA/VRTX

Hub-level FAQ points readers to the deeper analysis pages.

What is the current bcba/VRTX stock rating?

bcba/VRTX is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full bcba/VRTX analysis?

The full report lives at /stocks/bcba/VRTX/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for bcba/VRTX?

The latest report frames bcba/VRTX around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the bcba/VRTX page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.